- IR News
- News Releases
-
- Jul. 07, 2020 (PDF/224KB)R&D
- Sunovion Announces Topline Results from Global Phase 2 Study of SEP-4199 in Patients with Bipolar I Depression
-
- Jun. 30, 2020Others
- Posted Factbook 2020
-
- Jun. 24, 2020 (PDF/50KB)R&D
- Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis
-
- Jun. 23, 2020 (PDF/50KB)R&D
- Myovant Sciences Announces Priority Review and FDA Acceptance of New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer
-
- Jul. 07, 2020 (PDF/224KB)R&D
- Sunovion Announces Topline Results from Global Phase 2 Study of SEP-4199 in Patients with Bipolar I Depression
-
- Jun. 24, 2020 (PDF/50KB)R&D
- Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis
-
- Jun. 23, 2020 (PDF/50KB)R&D
- Myovant Sciences Announces Priority Review and FDA Acceptance of New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer
IR Calendar
-
- Jul. 30, 2020
- 1st Quarter of FY2020 financial results announcement (3:30pm JST) (Planned)
-
Recommended Information Rankings
